Literature DB >> 19221832

A comparative study of myocardial injury during conventional and endovascular aortic aneurysm repair: measurement of cardiac troponin T and plasma cytokine release.

M C Barry1, J M Hendriks, L C van Dijk, P Pattynama, D Poldermans, D Bouchier Hayes, H van Urk, M R H M van Sambeek.   

Abstract

BACKGROUND: Major aortic surgery results in significant haemodynamic and oxidative stress to the myocardium. Cytokine release is a major factor in causing cardiac injury during aortic surgery. Endovascular aortic aneurysm repair (EVAR) has the potential to reduce the severity of the ischaemia reperfusion syndrome and its systemic consequences. AIM: The aim of this study was to investigate the occurrence of myocardial injury during conventional and endovascular abdominal aortic aneurysm repair using measurement of the myocardial-specific protein, cardiac troponin T. Interleukin-6 was also measured in both groups and haemodynamic responses to surgery assessed.
METHODS: Nine consecutive patients undergoing conventional infra-renal aortic aneurysm surgery were compared with 13 patients who underwent EVAR. Patients were allocated on the basis of aneurysm morphology and suitability for endovascular repair.
RESULTS: Patients undergoing open repair had significantly more haemodynamic disturbance than those having endovascular repair (mean arterial pressure at 5 min following unclamping or balloon deflation: open (69.6 + 3.3 mmHg); endovascular (86 + 4.4 mmHg), P < 0.05 vs. pre-op). Troponin T levels at 48 h post-operatively were higher in patients who underwent open repair (open 0.164 + 0.1 ng/ml; endovascular 0.008 + 0.0005 ng/ml, P < 0.04). Significantly more patients in the open repair group had troponin T levels > 0.1 ng/l when compared with the endovascular group (P < 0.01, chi (2) test)
CONCLUSION: Endovascular aortic surgery produces significantly less myocardial injury than the open technique of aortic aneurysm repair.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19221832     DOI: 10.1007/s11845-009-0282-z

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  30 in total

1.  [Interleukin pattern, procalcitonin level and cellular immune status after endovascular aneurysm surgery].

Authors:  T Bürger; A Heucke; Z Halloul; J Tautenhahn; B Matthies; U Schmidt; D Kunz
Journal:  Zentralbl Chir       Date:  2000       Impact factor: 0.942

Review 2.  Pathophysiology of ischaemia reperfusion injury: central role of the neutrophil.

Authors:  C R Welbourn; G Goldman; I S Paterson; C R Valeri; D Shepro; H B Hechtman
Journal:  Br J Surg       Date:  1991-06       Impact factor: 6.939

3.  Noncardiogenic pulmonary edema after abdominal aortic aneurysm surgery.

Authors:  I S Paterson; J M Klausner; R Pugatch; P Allen; J A Mannick; D Shepro; H B Hechtman
Journal:  Ann Surg       Date:  1989-02       Impact factor: 12.969

4.  Cardiac response and complications during endovascular repair of abdominal aortic aneurysms: a concurrent comparison with open surgery.

Authors:  P W Cuypers; M Gardien; J Buth; J Charbon; C H Peels; W Hop; R J Laheij
Journal:  J Vasc Surg       Date:  2001-02       Impact factor: 4.268

5.  A randomized trial comparing conventional and endovascular repair of abdominal aortic aneurysms.

Authors:  Monique Prinssen; Eric L G Verhoeven; Jaap Buth; Philippe W M Cuypers; Marc R H M van Sambeek; Ron Balm; Erik Buskens; Diederick E Grobbee; Jan D Blankensteijn
Journal:  N Engl J Med       Date:  2004-10-14       Impact factor: 91.245

6.  Long-term prognostic value of asymptomatic cardiac troponin T elevations in patients after major vascular surgery.

Authors:  M D Kertai; E Boersma; J Klein; H Van Urk; J J Bax; D Poldermans
Journal:  Eur J Vasc Endovasc Surg       Date:  2004-07       Impact factor: 7.069

7.  Adverse reactions during endovascular treatment of aortic aneurysms may be triggered by interleukin 6 release from the thrombotic content.

Authors:  P Swartbol; L Truedsson; L Norgren
Journal:  J Vasc Surg       Date:  1998-10       Impact factor: 4.268

8.  Postoperative fever, bowel ischaemia and cytokine response to abdominal aortic aneurysm repair--a comparison between endovascular and open surgery.

Authors:  I Syk; J Brunkwall; K Ivancev; B Lindblad; A Montgomery; E Wellander; J Wisniewski; B Risberg
Journal:  Eur J Vasc Endovasc Surg       Date:  1998-05       Impact factor: 7.069

Review 9.  Tumor necrosis factor-alpha as a myocardial depressant substance.

Authors:  M Odeh
Journal:  Int J Cardiol       Date:  1993-12-31       Impact factor: 4.164

10.  Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum.

Authors:  A Kumar; V Thota; L Dee; J Olson; E Uretz; J E Parrillo
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

View more
  3 in total

1.  Microparticles in nasal lavage fluids in chronic rhinosinusitis: Potential biomarkers for diagnosis of aspirin-exacerbated respiratory disease.

Authors:  Toru Takahashi; Atsushi Kato; Sergejs Berdnikovs; Whitney W Stevens; Lydia A Suh; James E Norton; Roderick G Carter; Kathleen E Harris; Anju T Peters; Kathryn E Hulse; Leslie C Grammer; Kevin C Welch; Stephanie Shintani-Smith; Bruce K Tan; David B Conley; Robert C Kern; Bruce S Bochner; Robert P Schleimer
Journal:  J Allergy Clin Immunol       Date:  2017-02-24       Impact factor: 10.793

2.  A Retrospective Analysis of Comparison of General Versus Regional Anaesthesia for Endovascular Repair of Abdominal Aortic Aneurysm.

Authors:  Özgür Yağan; Kadir Özyılmaz; Nilay Taş; Volkan Hancı
Journal:  Turk J Anaesthesiol Reanim       Date:  2014-09-09

Review 3.  Cytokines as biomarkers of inflammatory response after open versus endovascular repair of abdominal aortic aneurysms: a systematic review.

Authors:  Diamantis I Tsilimigras; Fragiska Sigala; Georgios Karaolanis; Ioannis Ntanasis-Stathopoulos; Eleftherios Spartalis; Michael Spartalis; Nikolaos Patelis; Alexandros Papalampros; Chandler Long; Demetrios Moris
Journal:  Acta Pharmacol Sin       Date:  2018-05-17       Impact factor: 6.150

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.